The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
Clinical trial NCT00001114 · COMPLETED
Trial details
- NCT number
- NCT00001114
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.